Earnings Feed
Start Free
Home/Filings/4/A/0001209191-13-013991
4/A//SEC Filing

SHOLTIS MARTYN R 4/A

Accession 0001209191-13-013991

CIK 0000868368other
View on SEC.govCompany Profile

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 4:42 PM ET

Size

23.2 KB

Accession

0001209191-13-013991

Insider Transaction Report

Form 4/AAmended
Period: 2013-02-28
ROCHESTER MEDICAL CORPORATIONROCM
SHOLTIS MARTYN R
Corporate Vice President
Transactions
  • Sale

    Common Stock

    2013-02-28$14.80/sh−1,500$22,203→ 40,000 total
  • Exercise/Conversion

    Common Stock

    2013-03-01$4.70/sh+3,000$14,100→ 55,000 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2013-03-01−12,000→ 0 total
    Exercise: $4.63From: 2005-01-02Exp: 2014-01-02→ Common Stock (12,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2013-03-01−3,000→ 27,000 total
    Exercise: $4.70From: 2006-01-01Exp: 2015-01-01→ Common Stock (30,000 underlying)
  • Sale

    Common Stock

    2013-03-01$14.75/sh−15,000$221,250→ 40,000 total
  • Exercise/Conversion

    Common Stock

    2013-03-01$4.63/sh+12,000$55,500→ 52,000 total
Holdings

  • Stock Option (Right to Buy)

    Exercise: $11.23From: 2009-02-06Exp: 2018-02-06→ Common Stock (20,000 underlying)
    20,000

  • Stock Option (Right to Buy)

    Exercise: $11.27From: 2010-02-03Exp: 2019-02-03→ Common Stock (20,000 underlying)
    20,000

  • Common Stock

    41,500

  • Stock Option (Right to Buy)

    Exercise: $5.70From: 2007-01-26Exp: 2016-01-26→ Common Stock (20,000 underlying)
    20,000

  • Stock Option (Right to Buy)

    Exercise: $12.30From: 2007-11-21Exp: 2016-11-21→ Common Stock (20,000 underlying)
    20,000

  • Stock Option (Right to Buy)

    Exercise: $12.27From: 2011-01-28Exp: 2020-01-28→ Common Stock (20,000 underlying)
    20,000

  • Stock Option (Right to Buy)

    Exercise: $10.72From: 2012-01-27Exp: 2021-01-27→ Common Stock (20,000 underlying)
    20,000
Footnotes (5)
  • [F1]Includes restricted stock award shares.
  • [F2]The amount of shares held has been adjusted to reflect an increase of 1,500 shares reported on a Form 4 reporting a 2011 purchase filed concurrently with this amendment. These shares were also omitted from one interim Form 4 filed in December 2012.
  • [F3]The price in Column 4 is a weighted average. The prices actually received ranged from $14.79 to $14.85. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F4]Amends incorrect share and option amounts reported on a Form 4 filed March 4, 2013. Total options exercised were 15,000 not 16,500 as reported on prior filing.
  • [F5]Vest as to 25% annual cumulative installments beginning one year from date of grant, beginning the date shown.

Documents

1 file

Issuer

ROCHESTER MEDICAL CORPORATION

CIK 0000868368

→
Entity typeother

Related Parties

1
  • filerCIK 0001211656

Filing Metadata

Form type
4/A
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:42 PM ET
Size
23.2 KB
View on SEC.gov